A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Eastern Cooperative Oncology Group
Roswell Park Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
CTI BioPharma
Masonic Cancer Center, University of Minnesota
Jonsson Comprehensive Cancer Center
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Boston Children's Hospital
Dana-Farber Cancer Institute
Nohla Therapeutics, Inc.
Case Comprehensive Cancer Center
University of Washington
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Wake Forest University Health Sciences
National Cancer Institute (NCI)
Cedars-Sinai Medical Center
University of California, Davis
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
OHSU Knight Cancer Institute
National Cancer Institute (NCI)
Traws Pharma, Inc.
Fred Hutchinson Cancer Center
Ohio State University Comprehensive Cancer Center
University of Rochester
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Asan Medical Center
SWOG Cancer Research Network
Fred Hutchinson Cancer Center
Mesoblast, Ltd.
Cellerant Therapeutics
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
University of Chicago
National Cancer Institute (NCI)